Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |